2 years ago
CRVO
AnalystsSoumit RoySoumit Roy's Stock Forecasts
AnalystsSoumit Roy
Analyst Ranking
Top 23%
#1257 out of 5511 analysts
Average Return
+5.7%
Win Rate
30%12 out of 40
Risk vs Reward
Poor
Good
Soumit Roy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +727.79% | $3.85 | $31.87 | 2024-04-11 - 2025-04-10 | Strong Buy |
Enliven Therapeutics IncELVN | +145.20% | $16.86 | $41.34 | 2025-05-16 - 2026-05-15 | Strong Buy |
Cg Oncology IncCGON | +121.64% | $33.69 | $74.67 | 2025-09-08 - 2026-09-04 | Strong Buy |
Elicio Therapeutics IncELTX | +117.14% | $4.26 | $9.25 | 2024-10-31 - 2025-10-30 | Strong Buy |
Deciphera Pharmaceuticals IncDCPH | +110.84% | $11.99 | $25.28 | 2023-10-31 - 2024-04-29 | Strong Buy |
Soumit Roy Analyst Color
Get additional color on Soumit Roy's coverage of popular stocks
Soumit Roy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Editas Medicine IncEDIT | 2 | Strong Buy | $8.00 | +204.18% | Upgrades | 6 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Hold | $21.50 | -0.14% | Downgrades | 6 months ago |
Whitehawk Therapeutics IncWHWK | 1 | Strong Buy | $7.00 | +71.15% | Initiates Coverage On | 9 months ago |
Context Therapeutics IncCNTX | 1 | Strong Buy | $7.00 | +1,823.08% | Initiates Coverage On | 9 months ago |
Evaxion AEVAX | 1 | Strong Buy | $10.00 | +228.95% | Initiates Coverage On | a year ago |
Anavex Life Sciences CorpAVXL | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Atyr Pharma IncATYR | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Cg Oncology IncCGON | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | a year ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | a year ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | a year ago |
Enliven Therapeutics IncELVN | 2 | Strong Buy | $27.00 | N/A | Maintains | a year ago |
Acrivon Therapeutics IncACRV | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Oncolytics Biotech IncONCY | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Mural Oncology PLCMURA | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Cervomed IncCRVO | 3 | Strong Buy | $15.00 | N/A | Upgrades | 2 years ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Beam Therapeutics IncBEAM | 2 | Strong Buy | $34.00 | N/A | Upgrades | 2 years ago |
Chimerix IncCMRX | 1 | Hold | $8.55 | N/A | Downgrades | 2 years ago |
In8bio IncINAB | 4 | Strong Buy | $36.00 | N/A | Upgrades | 2 years ago |
Onkure Therapeutics IncOKUR | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 2 years ago |
Essa Pharma IncEPIX | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Elicio Therapeutics IncELTX | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 2 years ago |
Oric Pharmaceuticals IncORIC | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Adicet Bio IncACET | 2 | Strong Buy | $64.00 | N/A | Maintains | 2 years ago |
Bolt Biotherapeutics IncBOLT | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 3 | Hold | $25.60 | N/A | Downgrades | 2 years ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $26.00 | N/A | Maintains | 2 years ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 2 years ago |
Monopar TherapeuticsMNPR | 2 | Strong Buy | $10.00 | N/A | Upgrades | 2 years ago |
Tracon Pharmaceuticals IncTCON | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Rain Enhancement Technologies Holdco IncRAIN | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Z Squared IncZSQR | 1 | Strong Buy | $80.00 | N/A | Initiates Coverage On | 3 years ago |
Inhibikase Therapeutics IncIKT | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Hcw Biologics IncHCWB | 1 | Strong Buy | $1,920.00 | N/A | Initiates Coverage On | 4 years ago |
Aveo Pharmaceuticals IncAVEO | 1 | Hold | $15.00 | N/A | Downgrades | 4 years ago |
Rain Oncology IncRAIN2 | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 4 years ago |
Ars Pharmaceuticals IncSPRY | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Celyad Oncology SaCYADY | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Filana Therapeutics IncFLNA | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 5 years ago |
Precision Biosciences IncDTIL | 1 | Strong Buy | $810.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.